Management of Retinal Vein Occlusion - Hariprasad, Seenu
200,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
100 °P sammeln
  • Gebundenes Buch

Management of retinal venous occlusions (RVO) has changed dramatically in recent years. With an increase in medical information, technological advances, and clinical trials, ophthalmologists need a concise, updated reference. Management of Retinal Vein Occlusion: Current Concepts fills this current need in the market.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Management of retinal venous occlusions (RVO) has changed dramatically in recent years. With an increase in medical information, technological advances, and clinical trials, ophthalmologists need a concise, updated reference. Management of Retinal Vein Occlusion: Current Concepts fills this current need in the market.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Seenu M. Hariprasad, MD is a Professor at the University of Chicago, Department of Ophthalmology and Visual Sciences, Pritzker School of Medicine in Illinois, where he serves as Chief of the Vitreoretinal Service. After receiving his Bachelor of Arts degree from Cornell University in Ithaca, NY and graduating with Distinction in Neuroscience, Dr. Hariprasad went on to receive his Medical Degree from the University of Pennsylvania in Philadelphia, where he was elected into Alpha Omega Alpha. He completed both his transitional internship and ophthalmology residency at Baylor College of Medicine's Cullen Eye Institute in Houston, TX, where he received numerous research awards. Dr. Hariprasad then spent 2 years at Washington University's Barnes Retina Institute in St. Louis, MO, where he completed a Fellowship in the Diseases and Surgery of the Retina, Macula, and Vitreous. Dr. Hariprasad is actively involved in clinical research, having been principal investigator or sub-investigator in nearly 50 national clinical trials evaluating new drugs, devices, and surgical innovations for age-related macular degeneration, retinal vascular occlusion, uveitis, endophthalmitis, and diabetic eye disease. His efforts in research have resulted in more than 140 peer-reviewed publications, meeting abstracts, and textbook chapters. He currently holds the position of Director of Ophthalmic Clinical Research at the University of Chicago. In addition to serving on the Editorial Board for the American Journal of Ophthalmology, Dr. Hariprasad is also a scientific referee for 12 major ophthalmology journals. Additionally, he serves on the Editorial Board for OSLI Retina, Retinal Physician, and Ocular Surgery News. He is also co-founder of the CONNECT Network, a collaborative association of academic vitreoretinal specialists dedicated to furthering the vitreoretinal subspecialty through various research and educational endeavors. Dr. Hariprasad has presented a vast number of lectures at scientific meetings, as well as guest lectureships both nationally and internationally. He has trained numerous residents and currently is Director of the Surgical Retina Fellowship Program at the University of Chicago. Dr. Hariprasad is board certified by the American Board of Ophthalmology and is a member of the American Medical Association, American Academy of Ophthalmology, Macula Society, Retina Society, American Society of Retinal Specialists, Association for Research in Vision and Ophthalmology, Club Vit, and the Chicago Ophthalmological Society. From 2007 to present, the Consumer Research Council of America has selected him as one of "America's Top Ophthalmologists." Becker's ASC Review has named him as one of "135 Leading Ophthalmologists in America," and he is listed as one of Castle Connolly/US News & World Report "America's Top Doctors." In 2014, he was listed in the Chicago Magazine Biennial List of Outstanding Doctors. Dr. Hariprasad has received Honor Achievement Awards from both the American Academy of Ophthalmology and the American Society of Retina Specialists.